557 Short-term Rho-associated kinase inhibitor treatment accelerates primary keratinocyte growth without affecting the characteristics of the stem cell population

Saved in:
Bibliographic Details
Published inJournal of investigative dermatology Vol. 142; no. 12; p. S277
Main Authors Jayarajan, V., Hall, G.T., Xenakis, T., Bulstrode, N., Moulding, D., Castellano, S., W DI
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.12.2022
Online AccessGet full text

Cover

More Information
ISSN:0022-202X
1523-1747
DOI:10.1016/j.jid.2022.09.573